Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 34/75 ]
NYSE | Common Stock
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.
It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands.
In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products.
Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum.
It sells its products through direct sales organizations and distributors.
The company was incorporated in 2004 and is based in Alameda, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 25, 26 | 1.18 Increased by +21.65% | 1.10 Increased by +7.27% |
| Nov 5, 25 | 0.97 Increased by +14.12% | 0.93 Increased by +4.70% |
| Jul 29, 25 | 0.86 Increased by +34.37% | 0.83 Increased by +3.61% |
| May 5, 25 | 0.83 Increased by +102.44% | 0.75 Increased by +9.98% |
| Feb 20, 25 | 0.97 Increased by +27.63% | 0.89 Increased by +8.54% |
| Oct 30, 24 | 0.85 Increased by +26.87% | 0.69 Increased by +23.19% |
| Jul 30, 24 | 0.64 Increased by +48.84% | 0.56 Increased by +14.29% |
| May 7, 24 | 0.41 Increased by +78.26% | 0.38 Increased by +7.89% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 385.38 M Increased by +22.14% | 47.34 M Increased by +40.55% | Increased by +12.28% Increased by +15.07% |
| Sep 30, 25 | 354.69 M Increased by +17.82% | 45.85 M Increased by +55.28% | Increased by +12.93% Increased by +31.80% |
| Jun 30, 25 | 339.45 M Increased by +13.38% | 45.27 M Increased by +175.20% | Increased by +13.34% Increased by +166.33% |
| Mar 31, 25 | 324.14 M Increased by +16.32% | 39.22 M Increased by +256.51% | Increased by +12.10% Increased by +206.48% |
| Dec 31, 24 | 315.52 M Increased by +10.83% | 33.68 M Decreased by -37.87% | Increased by +10.68% Decreased by -43.95% |
| Sep 30, 24 | 301.04 M Increased by +11.11% | 29.53 M Increased by +220.46% | Increased by +9.81% Increased by +188.42% |
| Jun 30, 24 | 299.40 M Increased by +14.49% | -60.20 M Decreased by -417.51% | Decreased by -20.11% Decreased by -377.31% |
| Mar 31, 24 | 278.65 M Increased by +15.43% | 11.00 M Increased by +28.50% | Increased by +3.95% Increased by +11.32% |